Global Analgesics Market is expected to garner $26.4 billion : New Technology, Application, Type, Customer Segments, and Top Key Players Global Analgesics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $26.4 billion by 2022, registering a CAGR of 7.7% during the period 2015-2022. The non-opioids segment would continue to be the highest revenue-generating segment throughout the forecast period. North America and Europe, are likely to continue their lead through 2022; they collectively accounted for over half of the overall market share in the global analgesics market in 2015.
Request sample for this report: www.alliedmarketresearch.com/request-sample/1254 Frequent pain and aches experienced by the ageing population, increasing incidences of cardiovascular disease (CVD), cancer, & arthritis, and rising investments in R&D by the public & private sectors, with key focus on the classes of compounds to formulate new therapeutics, are the major factors boosting the market growth. However, factors such as uncontrolled prescriptions of opioids and drug abuse, leading to approximately 28,000 deaths in the U.S. every year, and insufficient regulatory guidelines, especially against opioid analgesics, are likely to impede the market growth. Furthermore, the increase in popularity of personalized medicine is expected to provide numerous growth opportunities for the analgesics market in the near future.